Formulation development and in vitro evaluation of gastroretentive hollow microspheres of famotidine

被引:7
作者
Chordiya, Mayur A. [1 ]
Gangurde, Hemant H. [1 ]
Senthilkumaran, K. [2 ]
Kothari, Lokesh P. [1 ]
机构
[1] SNJBs Shriman Suresh Dada Jain Coll Pharm, Dept Pharmaceut, Nasik, Maharashtra, India
[2] KK Coll Pharm, Madras, Tamil Nadu, India
关键词
Cellulose acetate; emulsion solvent diffusion; Eudragit RL 100; Higuchi's model; scanning electron microscopy;
D O I
10.4103/2230-973X.82423
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The main aim of this study was to develop a gastroretentive, multiple-unit floating drug delivery system for a drug which is poorly absorbed from the lower gastrointestinal tract. Such a dosage form may provide an extended retention of drug in the upper gastrointestinal tract resulting in enhanced absorption and improved bioavailability. Materials and Methods: Microspheres were prepared by the emulsion solvent diffusion method. Four different ratios (1:1, 1:2, 1:3, and 1:4) from each polymer, i.e., Eudragit RL 100 (E1-E4) and cellulose acetate (C1-C4) were prepared. Results: Hollow microspheres were characterized by particle size using optical microscopy. The in vitro release data obtained for the formulations E1-E4 and C1-C4 showed good entrapment efficiency, good percentage buoyancy, and prolonged drug release. The in vitro drug release showed the highest regression coefficient values for Higuchi's model, indicating diffusion to be the predominant mechanism of drug release. The surface and cross-sectional morphology of the formulations E1-A and C1-A were determined using scanning electron microscopy. Conclusions: Thus, prepared floating hollow microspheres of famotidine may prove to be potential candidates for the multiple-unit drug delivery device adaptable for any intragastric condition.
引用
收藏
页码:105 / 111
页数:7
相关论文
共 13 条
[1]  
[Anonymous], 1962, HDB PHARM EXCIPIENTS, V11, P302
[2]   Chitosan as a nasal delivery system: The effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers [J].
Aspden, TJ ;
Mason, JDT ;
Jones, NS ;
Lowe, J ;
Skaugrud, O ;
Illum, L .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (04) :509-513
[3]  
Aulton ME, 2002, PHARM SCI DOSAGE FOR, P315
[4]   Development of hollow/porous calcium pectinate beads for floating-pulsatile drug delivery [J].
Badve, Shraddha S. ;
Sher, Praveen ;
Korde, Aruna ;
Pawar, Atmaram P. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 65 (01) :85-93
[5]  
Brahmankar DM, 2003, BIOPHARMACEUTICS PHA, V1st, P335
[6]  
Chein YW, 1992, NOVEL DRUG DELIVERY, P1
[7]   Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: Preparation and in vitro characterization [J].
Jain, SK ;
Awasthi, AM ;
Jain, NK ;
Agrawal, GP .
JOURNAL OF CONTROLLED RELEASE, 2005, 107 (02) :300-309
[8]  
LEE TW, 2001, REMINGTON SCI PRACTI, P903
[9]   In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method [J].
Sato, Y ;
Kawashima, Y ;
Takeuchi, H ;
Yamamoto, H .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (02) :235-243
[10]   Low density multiparticulate system for pulsatile release of meloxicam [J].
Sharma, S ;
Pawar, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 313 (1-2) :150-158